Skip to content

Clinical trials

Phase 2 Breast Neoplasms, Male trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms, Male Phase: Phase 2 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
20026
20034
20049
200516
20065
200711
20087
200910
20106
20113
20121
20133
20171
20182
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Terminated17
Unknown status5
Withdrawn4
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
Alliance for Clinical Trials in Oncology14
University of Washington4
Case Comprehensive Cancer Center3
City of Hope Medical Center3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
H. Lee Moffitt Cancer Center and Research Institute2
Memorial Sloan Kettering Cancer Center2
NCIC Clinical Trials Group2
National Institutes of Health Clinical Center (CC)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms, Male102
Breast Neoplasms99
Triple Negative Breast Neoplasms8
Neoplasm Metastasis6
Brain Neoplasms5
Inflammatory Breast Neoplasms5
Carcinoma, Ductal, Breast4
Carcinoma, Lobular3
Carcinoma, Intraductal, Noninfiltrating2
Cardiotoxicity2

Trials

Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.